FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2023/03/050356 [Registered on: 06/03/2023] Trial Registered Prospectively
Last Modified On: 21/02/2023
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Physiotherapy (Not Including YOGA) 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Retraining of balance, nerve glide exercises, resistance training, and instruction in daily living skills are effective treatments for chemotherapy-induced peripheral neuropathy in cancer survivor 
Scientific Title of Study   Efficacy of balance re-education, neural mobilisation, resistive and activities of daily living training on chemotherapy induced peripheral neuropathy in cancer survivors: Two arm randomised controlled trial 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  HIMANSHU GAKHAR 
Designation  POST GRADUATE STUDENT  
Affiliation  AMAR JYOTI INSTITUTE OF PHYSIOTHERAPY 
Address  Karkar Duma, Karkardooma, Anand Vihar, Delhi, 110092

New Delhi
DELHI
110045
India 
Phone  7982602897  
Fax    
Email  gakharhimanshu793@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  DR NIDHI SINGH PT 
Designation  ASSISTANT PROFESSOR 
Affiliation  AMAR JYOTI INSTITUTE OF PHYSIOTHERAPY 
Address  AMAR JYOTI INSTITUTE OF PHYSIOTHERAPY, KARKARDOOMA, VIKAS MARG, NEW DELHI- 110092 EAST DELHI 110092 INDIA

East
DELHI
110092
India 
Phone    
Fax    
Email  nidhi.singh2411@gmail.com  
 
Details of Contact Person
Public Query
 
Name  DR NIDHI SINGH PT 
Designation  ASSISTANT PROFESSOR 
Affiliation  AMAR JYOTI INSTITUTE OF PHYSIOTHERAPY 
Address  AMAR JYOTI INSTITUTE OF PHYSIOTHERAPY, KARKARDOOMA, VIKAS MARG, NEW DELHI- 110092 EAST

East
DELHI
110092
India 
Phone    
Fax    
Email  nidhi.singh2411@gmail.com  
 
Source of Monetary or Material Support  
AMAR JYOTI INSTITUTE OF PHYSIOTHERAPY Karkar Duma, Karkardooma, Anand Vihar, Delhi, 110092 
 
Primary Sponsor  
Name  AMAR JYOTI INSTITUTE OF PHYSIOTHERAPY 
Address  AMAR JYOTI INSTITUTE OF PHYSIOTHERAPY, KARKARDOOMA, VIKAS MARG, NEW DELHI- 110092  
Type of Sponsor  Private medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Ajay Dabas   JIVISHA ADVANCE MEDICAL CENTER   2nd floor Chemotherapy ward Room number 1, 29, Paschim Vihar Extension, Paschim Vihar, Delhi, 110063
West
DELHI 
9811819057

dabas.ajay131@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 2  
Name of Committee  Approval Status 
AMAR JYOTI INSTITUIONAL REVIEW BOARD- ETHICAL COMMITTEE  Approved 
JIVISHA ADVANCE MEDICAL CENTER  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: C801||Malignant (primary) neoplasm, unspecified,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  balance re-education, neural mobilisation, resistive and activities of daily living training  1. Balance Re-education a. Standing on one foot b. Sit to stand c. Medio-lateral and Antero-posterior Perturbations d. Walking in figure of 8 2. Neural mobilisation 3. Resistive Training (with weight cuff) Front raise Lateral raise Knee Flexion- Extension Hip Flexion-Extension Ankle Dorsiflexion Ankle Plantar flexion 4. Activities of Daily Living training Walking Star climbing (5 steps) Shoe lacing The complete program lasted for 40-45 minutes for 3 weeks.  
Comparator Agent  Education regarding chemotherapy induced peripheral neuropathy its consequences and role of exercises.   Control participants will be given education, counseling without additional information about physical activity. During follow up, when all assessments are done, control group patients will have the opportunity to participate in the intervention described for a maximum of 3 weeks. 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  - Age 18-60 years had primary diagnosis of cancer
- Given chemotherapeutic regimen for atleast 1 cycle
- Both Male and female
- All types of cancer
- Had a karnofsky performance status ≥ 70
- Should be able to walk 3 meters
- Have at least 1 neuropathy symptom according to CIPN assessment tool (CIPNAT).
 
 
ExclusionCriteria 
Details  - Hereditary peripheral neuropathy .{ e.g., Charcot-marie-tooth disease}
- If they had other chronic neuropathic disease likes Diabetic Neuropathy, Multiple Sclerosis, Neuritis etc.
- Orthopaedic problem that affect balance (e.g. ACL reconstruction)
- Vestibular disorder and visual acuity problem
- Chronic inflammatory demyelinating polyneuropathy
- Concomitant disease like diabetes, renal insufficiencies
- Prior history of alcohol abuse
- Lower limb amputee
- Use of walking Aid
- Treatment with antiepileptic drugs, antidepressants and major analgesics.

 
 
Method of Generating Random Sequence    
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Investigator Blinded 
Primary Outcome  
Outcome  TimePoints 
Modified total neuropathy score A 6 -item tool that combines patient report of subjective sensory and motor symptoms, deep tendon reflexes, manual muscle testing of distal muscles, pin sensibility, and quantitative vibration thresholds.
• 0 -24 points, higher score indicates worse neuropathy.
 
will be assessed at baseline and after 3 weeks  
 
Secondary Outcome  
Outcome  TimePoints 
UNIPEDAL STANCE TEST

• Patients were asked to stand barefoot on the limb of their choice, with the other limb raised so that the raised foot was near but not touching the ankle of their stance limb.
• Prior to raising the limb, the subject was instructed to cross his arms over the chest.
• The investigator used a stopwatch to measure the amount of time the subject was able to stand on one limb.
• Time commenced when the subject raised the foot off the floor ended when the subject either
(1) used his arms (ie, uncrossed arms)
(2) used the raised foot (moved it toward or away from the standing limb or touched the floor)
(3) moved the weight-bearing foot to maintain his balance (ie, rotated foot on the ground)
(4) a maximum of 45 seconds had elapsed
(5) opened eyes on eyes closed trials.
 
The test/Questionaire will be assessed at the baseline and at the end of 3 weeks. (Pre and Post) 
timed up and go test  The test/Questionaire will be assessed at the baseline and at the end of 3 weeks. (Pre and Post) 
functional independence measure   The test/Questionaire will be assessed at the baseline and at the end of 3 weeks. (Pre and Post) 
 
Target Sample Size   Total Sample Size="28"
Sample Size from India="28" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   11/03/2023 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   none 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

There is rising prevalence of cancer, many individuals are living with side effects of its treatment, as chemotherapy is the mainline treatment. Few studies have been done to investigate potentially beneficial effects of specific exercise to counteract chemotherapy induced peripheral neuropathy symptoms in cancer survivors. The rehabilitative potential of exercise has been so far less investigated and the results are divergent. The majority of studies are done on non natives of India focusing on one or two protocols only at one time. So there is need to investigate the effect of balance Re-education, neural mobilisation, Resistive and activities of daily living training in chemotherapy induced peripheral neuropathy on cancer survivors.

In this study following procedure will be followed:


1. The purpose and benefit of the research will be explained to the cancer survivors having Chemotherapy induced peripheral neuropathy 

2. Consent for participation in research will be taken from the patients

3. Meeting the inclusion and exclusion criteria

4.Baseline assessment will be performed                              

 

                          Patient divided into two groups

                                                       

EXPERIMENTAL GROUP

CONTROL GROUP

N = 14

N = 14

Will be given intervention exercises, With proper guidance, counseling and precautions.                                                    

Education regarding chemotherapy induced peripheral neuropathy its consequences and role of exercises.

 


 
Close